![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
Preview |
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
856kB |
| Item Type: | Review |
|---|---|
| Title: | Cardiovascular programming during and after diabetic pregnancy: role of placental dysfunction and IUGR |
| Creators Name: | Langmia, I.M., Kräker, K., Weiss, S.E., Haase, N., Schütte, T., Herse, F. and Dechend, R. |
| Abstract: | Intrauterine growth restriction (IUGR) is a condition whereby a fetus is unable to achieve its genetically determined potential size. IUGR is a global health challenge due to high mortality and morbidity amongst affected neonates. It is a multifactorial condition caused by maternal, fetal, placental, and genetic confounders. Babies born of diabetic pregnancies are usually large for gestational age but under certain conditions whereby prolonged uncontrolled hyperglycemia leads to placental dysfunction, the outcome of the pregnancy is an intrauterine growth restricted fetus with clinical features of malnutrition. Placental dysfunction leads to undernutrition and hypoxia, which triggers gene modification in the developing fetus due to fetal adaptation to adverse utero environmental conditions. Thus, in utero gene modification results in future cardiovascular programming in postnatal and adult life. Ongoing research aims to broaden our understanding of the molecular mechanisms and pathological pathways involved in fetal programming due to IUGR. There is a need for the development of effective preventive and therapeutic strategies for the management of growth-restricted infants. Information on the mechanisms involved with in utero epigenetic modification leading to development of cardiovascular disease in adult life will increase our understanding and allow the identification of susceptible individuals as well as the design of targeted prevention strategies. This article aims to systematically review the latest molecular mechanisms involved in the pathogenesis of IUGR in cardiovascular programming. Animal models of IUGR that used nutrient restriction and hypoxia to mimic the clinical conditions in humans of reduced flow of nutrients and oxygen to the fetus will be discussed in terms of cardiac remodeling and epigenetic programming of cardiovascular disease. Experimental evidence of long-term fetal programming due to IUGR will also be included. |
| Keywords: | Diabetes, Placental Dysfunction, Gene Modification, Intra Uterine Growth Restriction, Cardiovascular Programming |
| Source: | Frontiers in Endocrinology |
| ISSN: | 1664-2392 |
| Publisher: | Frontiers Media SA |
| Volume: | 10 |
| Page Range: | 215 |
| Date: | April 2019 |
| Official Publication: | https://doi.org/10.3389/fendo.2019.00215 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
